BY MARKETWIRE
-
Lundbeck CEO positively surprised by pipeline – acquisition only one of several options
Because Charl van Zyl signed up with the business on Sept. 1 in 2015, Lundbeck’s B-share has actually raised by 26.5%.
-
Coloplast CEO sells shares and makes USD 0,75 million
The inventory choices have been exercised on Friday and the shares have been offered on the identical day.
-
Bavarian Nordic wins 150,000-dose Mpox vaccination order from UK authorities
In the U.K., they are mosting likely to immunize teams that go to greater threat of obtaining revealed to mpox.
-
Korro Bio partners with Novo Nordisk to develop two drug candidates
The offer can send out millions in the direction of the British firm.
-
Novo Nordisk reports typical side effect profile for weight loss hope
Novo Nordisk is to offer its much awaited stage I information for fat burning medication amycretin at 11 am.
-
Novo Nordisk exercises option to license molecule for potential obesity treatment
The choice belongs to a cooperation in between Novo and Kallyope from 2018.
-
Bavarian Nordic’s mpox vaccine approved by WHO
The authorization will certainly aid increase accessibility to the injection in all African nations.
-
Novo Nordisk sued by former US employees
The previous staff members think Novo Nordisk’s pension plan plan has “dramatically” underperformed.
-
Newly acquired drug from Genmab shows promising results
chief executive officer Jan van de Winkel has actually formerly interacted that the outcomes create the basis for launching Stage III research studies with Rina-S later on this yea…
-
Bavarian Nordic to produce additional mpox vaccines this year
Bavarian Nordic has actually delivered 250,000 dosages thus far, while one more 500,000 contributed dosages have actually been gotten.